Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer

Cancer Science

Volumn 107, Issue 1, 2016, Pages 84-94

  Kurozumi, Akira ^a   Goto, Yusuke ^a   Matsushita, Ryosuke ^b   Fukumoto, Ichiro ^a   Kato, Mayuko ^a   Nishikawa, Rika ^a   Sakamoto, Shinichi ^a   Enokida, Hideki ^b   Nakagawa, Masayuki ^b   Ichikawa, Tomohiko ^a   Seki, Naohiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

ITGA3; ITGB1; microRNA; miR 223; Prostate cancer

Indexed keywords

INTEGRIN; INTEGRIN A3; INTEGRIN B1; MICRORNA 223; UNCLASSIFIED DRUG; ALPHA3 INTEGRIN; BETA1 INTEGRIN; ITGA3 PROTEIN, HUMAN; MICRORNA; MIRN223 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COMPUTER MODEL; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; INVESTIGATIVE PROCEDURES; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; VERY ELDERLY; CELL MOTION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PROSTATE TUMOR; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANTIGENS, CD29; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA3; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84956758495     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12842     Document Type: Article

References (40)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015; 65: 5-29.
2. Sridhar SS, Freedland SJ, Gleave ME et al. Castration-resistant prostate cancer: from new pathophysiology to new treatment. Eur Urol 2014; 65: 289-99.
3. Sturge J, Caley MP, Waxman J. Bone metastasis in prostate cancer: emerging therapeutic strategies. Nat Rev Clin Oncol 2011; 8: 357-68.
4. Fuse M, Kojima S, Enokida H et al. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer. J Hum Genet 2012; 57: 691-99.
5. Goto Y, Kojima S, Nishikawa R et al. The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer. Oncotarget 2014; 5: 7748-59.
6. Kojima S, Enokida H, Yoshino H et al. The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. J Hum Genet 2014; 59: 78-87.
7. Nishikawa R, Goto Y, Sakamoto S et al. Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. Cancer Sci 2014; 105: 802-11.
8. Goto Y, Nishikawa R, Kojima S et al. Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer. FEBS Lett 2014; 588: 1973-82.
9. Nishikawa R, Goto Y, Kojima S et al. Tumor-suppressive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer. Int J Oncol 2014; 45: 401-10.
10. Fuse M, Nohata N, Kojima S et al. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Int J Oncol 2011; 38: 1093-101.
11. Kojima S, Chiyomaru T, Kawakami K et al. Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. Br J Cancer 2012; 106: 405-13.
12. Szczyrba J, Loprich E, Wach S et al. The microRNA profile of prostate carcinoma obtained by deep sequencing. Mol Cancer Res 2010; 8: 529-38.
13. Goto Y, Kurozumi A, Enokida H, Ichikawa T, Seki N. Functional significance of aberrantly expressed microRNAs in prostate cancer. Int J Urol 2015; 22: 242-52.
14. Gilcrease MZ. Integrin signaling in epithelial cells. Cancer Lett 2007; 247: 1-25.
15. Givant-Horwitz V, Davidson B, Reich R. Laminin-induced signaling in tumor cells. Cancer Lett 2005; 223: 1-10.
16. Hidaka H, Seki N, Yoshino H et al. Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget 2012; 3: 44-57.
17. Kinoshita T, Nohata N, Hanazawa T et al. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. Br J Cancer 2013; 109: 2636-45.
18. Yoshino H, Chiyomaru T, Enokida H et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 2011; 104: 808-18.
19. Nohata N, Hanazawa T, Kikkawa N et al. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br J Cancer 2011; 105: 833-41.
20. Kozlowski JM, Fidler IJ, Campbell D, Xu ZL, Kaighn ME, Hart IR. Metastatic behavior of human tumor cell lines grown in the nude mouse. Cancer Res 1984; 44: 3522-29.
21. Sobel RE, Sadar MD. Cell lines used in prostate cancer research: a compendium of old and new lines-part 1. J Urol 2005; 173: 342-59.
22. Xu J, Yao Q, Hou Y et al. MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation. Biomed Pharmacother 2013; 67: 381-86.
23. Birnie KA, Yip YY, Ng DC et al. Loss of mir-223 and JNK signalling contribute to elevated stathmin in malignant pleural mesothelioma. Mol Cancer Res 2015; 13: 1106-18.
24. Jia CY, Li HH, Zhu XC et al. MiR-223 suppresses cell proliferation by targeting IGF-1R. PLoS ONE 2011; 6: e27008.
25. Bruchim I, Werner H. Targeting IGF-1 signaling pathways in gynecologic malignancies. Expert Opin Ther Targets 2013; 17: 307-20.
26. Wu L, Li H, Jia CY et al. MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett 2012; 586: 1038-43.
27. Wei Y, Yang J, Yi L et al. MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer. Sci Rep 2014; 4: 7546.
28. Li X, Zhang Y, Zhang H et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 2011; 9: 824-33.
29. Goto Y, Kojima S, Nishikawa R et al. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker. Br J Cancer 2015; 113: 1055-65.
30. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9: 102-14.
31. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009; 19: 92-105.
32. Goel HL, Alam N, Johnson IN, Languino LR. Integrin signaling aberrations in prostate cancer. Am J Transl Res 2009; 1: 211-20.
33. Goel HL, Li J, Kogan S, Languino LR. Integrins in prostate cancer progression. Endocr Relat Cancer 2008; 15: 657-64.
34. Fornaro M, Manes T, Languino LR. Integrins and prostate cancer metastases. Cancer Metastasis Rev 2001; 20: 321-31.
35. Han TS, Hur K, Xu G et al. MicroRNA-29c mediates initiation of gastric carcinogenesis by directly targeting ITGB1. Gut 2015; 64: 203-14.
36. Liu LX, Jiang HC, Liu ZH et al. Integrin gene expression profiles of human hepatocellular carcinoma. World J Gastroenterol 2002; 8: 631-37.
37. Lee YC, Jin JK, Cheng CJ et al. Targeting constitutively activated beta1 integrins inhibits prostate cancer metastasis. Mol Cancer Res 2013; 11: 405-17.
38. Jin JK, Tien PC, Cheng CJ et al. Talin1 phosphorylation activates beta1 integrins: a novel mechanism to promote prostate cancer bone metastasis. Oncogene 2015; 34: 1811-21.
39. Kinoshita T, Hanazawa T, Nohata N et al. Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget 2012; 3: 1386-400.
40. Sakamoto S, McCann RO, Dhir R, Kyprianou N. Talin1 promotes tumor invasion and metastasis via focal adhesion signaling and anoikis resistance. Cancer Res 2010; 70: 1885-95.